| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/20/2010 | WO2010055307A1 Methods of enhancing translocation of charged analytes through transmembrane protein pores |
| 05/20/2010 | WO2010055208A1 Modified avidins binding to small ligands |
| 05/20/2010 | WO2010055135A1 Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands |
| 05/20/2010 | WO2010055024A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
| 05/20/2010 | WO2010054807A1 Protein with promoting effects for axonal growth of neurons of central nervous system |
| 05/20/2010 | WO2010054667A1 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
| 05/20/2010 | WO2010054530A1 Method for preparing genetically engineered n-terminal acetylated thymosin alpha 1 |
| 05/20/2010 | WO2010054503A1 Anticoagulant polypeptides and uses thereof |
| 05/20/2010 | WO2010054482A1 Immunogenic human papillomavirus compositions |
| 05/20/2010 | WO2010054445A1 Detection of tannerella forsythia infection |
| 05/20/2010 | WO2010037395A3 Mhc multimers in cancer vaccines and immune monitoring |
| 05/20/2010 | WO2010036945A3 Nanoemulsion therapeutic compositions and methods of using the same |
| 05/20/2010 | WO2010035259A3 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll |
| 05/20/2010 | WO2010035107A3 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 05/20/2010 | WO2010034032A3 Methods for preparing purified polypeptide compositions |
| 05/20/2010 | WO2010033321A3 Novel bacillus thuringiensis gene with lepidopteran activity |
| 05/20/2010 | WO2010032008A3 Dendritic cell modulatory molecule |
| 05/20/2010 | WO2010032001A8 Sensor |
| 05/20/2010 | WO2010027948A3 Methods and compositions for increased alpha-prime beta-conglycinin soybeans |
| 05/20/2010 | WO2010014946A3 Halogen-stabilized insulin |
| 05/20/2010 | WO2010003065A3 Axmi-il 5, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use |
| 05/20/2010 | WO2009149931A3 Fatty acid binding protein in the pathogenesis of cardiac dysfunction |
| 05/20/2010 | WO2009106073A3 Mhc multimers in borrelia diagnostics and disease |
| 05/20/2010 | US20100125918 Enterovirus type 71 protein and method for production |
| 05/20/2010 | US20100125917 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE |
| 05/20/2010 | US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof |
| 05/20/2010 | US20100125130 Tumour necrosis factor binding ligands |
| 05/20/2010 | US20100125129 Thermostable Fusion Proteins and Thermostable Adjuvant |
| 05/20/2010 | US20100125127 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation |
| 05/20/2010 | US20100125101 Immunostimulatory nucleic acid molecules |
| 05/20/2010 | US20100124754 Cloning, Expression And Purification Of Recombinant Porcine Intrinsic Factor For Use In Diagnostic Assay |
| 05/20/2010 | US20100124556 Novel shigella protein antigens and methods |
| 05/20/2010 | CA2744120A1 A vaccinia virus protein a46 peptide and use thereof |
| 05/20/2010 | CA2743853A1 Novel hiv-2 isolate |
| 05/20/2010 | CA2743666A1 Optically-based stimulation of target cells and modifications thereto |
| 05/20/2010 | CA2743394A1 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
| 05/20/2010 | CA2743306A1 Human m2e peptide immunogens |
| 05/20/2010 | CA2743141A1 Compositions and methods of use for soluble thrombomodulin variants |
| 05/20/2010 | CA2741973A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
| 05/20/2010 | CA2741929A1 Suppression of cancer |
| 05/19/2010 | EP2187216A1 Novel liver cancer marker |
| 05/19/2010 | EP2186902A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 05/19/2010 | EP2186901A2 Mutations in the BCR-Abl-tyrosine kinase associated with resistance to STI-571 |
| 05/19/2010 | EP2186899A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 05/19/2010 | EP2186898A1 Flowering induction |
| 05/19/2010 | EP2186896A1 Cancer antigen peptides derived from WT1 |
| 05/19/2010 | EP2186889A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 05/19/2010 | EP2186888A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/19/2010 | EP2186887A1 Glucoamylase variants |
| 05/19/2010 | EP2186884A2 HCV-anti-core monoclonal antibody |
| 05/19/2010 | EP2186877A2 Cytokine concentration system |
| 05/19/2010 | EP2186830A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 05/19/2010 | EP2186826A1 Chimeric hirudin proteins |
| 05/19/2010 | EP2186825A1 Human-derived T cell receptors |
| 05/19/2010 | EP2186824A2 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 05/19/2010 | EP2186823A1 Gene therapy for renal failure |
| 05/19/2010 | EP2186822A1 Use of inhibitors of Plac8 activity for the modulation of adipogenesis |
| 05/19/2010 | EP2186821A1 Protein with promoting effects for axonal growth of neurons of central nervous system |
| 05/19/2010 | EP2186820A1 Protein-protein interactions in human immunodeficiency virus |
| 05/19/2010 | EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/19/2010 | EP2186526A1 Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action |
| 05/19/2010 | EP2186015A2 De-duplication in virtualized server and virtualized storage environments |
| 05/19/2010 | EP2185936A2 Diagnosis, staging and monitoring of inflammatory bowel disease |
| 05/19/2010 | EP2185723A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle |
| 05/19/2010 | EP2185699A2 New proteins for use in human and animal staphylococcus infections |
| 05/19/2010 | EP2185684A2 Cell carrier containing collagen |
| 05/19/2010 | EP2185588A1 Synthetic pulmonary surfactant peptides |
| 05/19/2010 | EP2185587A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same |
| 05/19/2010 | EP2185586A1 Immune modulation via c-type lectin |
| 05/19/2010 | EP2185585A1 Leptin fusion proteins |
| 05/19/2010 | EP2185584A1 Interferon fusion proteins |
| 05/19/2010 | EP2185583A2 Granulocyte colony stimulating factor |
| 05/19/2010 | EP2185582A2 Erythropoietin fusion proteins |
| 05/19/2010 | EP2185580A1 Lactation-associated polypeptides |
| 05/19/2010 | EP2185579A1 Complexes of grp94 with human immunoglobulin g |
| 05/19/2010 | EP2185578A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 05/19/2010 | EP2185577A2 Chlamydia antigens |
| 05/19/2010 | EP2185576A1 Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 05/19/2010 | EP2185575A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 05/19/2010 | EP2185192A2 Lentiviral gene transfer vectors and their medicinal applications |
| 05/19/2010 | EP2185183A2 Use of natriuretic peptides for treating angioedema syndromes |
| 05/19/2010 | EP2185170A1 Composition for long-acting peptide analogs |
| 05/19/2010 | EP2184987A1 Bi-dentate compounds as kinase inhibitors |
| 05/19/2010 | EP1957519B1 Production of highly functional, highly branched or hyperbranched polylysines |
| 05/19/2010 | EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 05/19/2010 | EP1737974B1 Methods for identifying proteins with starch phosphorylating enzymatic activity |
| 05/19/2010 | EP1689783B1 Mutated anti-cd22 antibodies and immunoconjugates |
| 05/19/2010 | EP1540010B1 Use of biomarkers for detecting ovarian cancer |
| 05/19/2010 | EP1214097B9 Nucleic acids encoding polyepitope polypeptides |
| 05/19/2010 | EP1115382B1 Immunogenic liposome compositions |
| 05/19/2010 | EP0907735B9 Modulators of tissue regeneration |
| 05/19/2010 | CN201473478U Production equipment of biological low-antigenicity active collagen |
| 05/19/2010 | CN1986562B Polypeptide segment capable of enhancing animal's antibody response and its application |
| 05/19/2010 | CN101711280A TEM8 peptides and vaccines comprising the same |
| 05/19/2010 | CN101711255A Modified globin proteins with altered electron transport pathway |
| 05/19/2010 | CN101710124A Enzyme linked immunological kit for detecting residue of ciprofloxacin in aquatic products |
| 05/19/2010 | CN101709302A Cobia MHC-II beta gene sequence |
| 05/19/2010 | CN101709086A New method for preparing cytochrome C |
| 05/19/2010 | CN101709085A Polyethylene glycol modified human serum albumin and preparation method thereof |
| 05/19/2010 | CN101709084A Optimized serial cytokines and application thereof in inducing pluripotent stem cells |